Nyheter m m


Immunovia AB15 min. fördröjning

Förändring0% Senast0,00 SEK
Köp Sälj Läs mer

Immunovia AB: Immunovia to participate in upcoming Investor Conferences in March

15:55 LUND, SWEDEN - Immunovia AB today announced that Mats Grahn, Chief Executive Officer, will participate and host one-on-one investor meetings at the following upcoming investor conferences: Carnegie Healthcare Seminar 2019 in Stockholm, Sweden Tuesday, March 5, 2019 ROTH Capitals 31st Annual Investor Conference in Dana Point, CA, USA March 17th- 19th, 2019 Vator Securities Unicorn Summit in Stockholm, Sweden Thursday, March 21, 2019 For details, please check: https://immunovia.com/investors/calendar/ For more information, please contact: Julie Silber Director of Investor Relations Email: julie.silber@immunovia.com Tel: +46 7 93 486 277 About Immunovia Immunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovias strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovias core technology platform, IMMray, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer. In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. (Source: www.immunovia.com) Immunovias shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit www.immunovia.com. ----------------------------------------------------------- http://news.cision.com/immunovia-ab/r/immunovia-to-participate-in-upcoming-investor-conferences-in-march,c2741721 https://mb.cision.com/Main/13121/2741721/991516.pdf © Cision

Finansiella instrument kan både öka och minska i värde. Det finns en risk att du inte får tillbaka de pengar du investerar. Innan du investerar i en fond bör du läsa informationsbroschyren som finns hos fondbolaget och faktabladet som du hittar i orderläggningsfönstret samt på fondens produktsida på nordnet.se.